Search
Selected Filters
Displaying 211–220 of 254 research results
-
Pixium Vision Reports Progress in Development of Two Advanced Bionic Retina Systems
Eye On the Cure Research NewsBoth approaches show strong, near-term potential for providing meaningful vision to people who are otherwise blind from retinal diseases such as retinitis pigmentosa and age-related macular degeneration (AMD).
-
Stem-Cell Therapy for Retinitis Pigmentosa Safe Thus Far in Early Human Study
Eye On the Cure Research NewsThe trial is one of the first-ever for a stem-cell-derived therapy for RP.
-
Eye On the Cure Research News
Dr. Weleber became the 10th recipient of the Foundation’s highest honor, named after FFB co-founder Lulie Gund, during the opening lunch of the VISIONS 2016 conference.
-
Eye On the Cure Research News
At VISIONS 2016, FFB’s national conference, the Foundation honored him with its Ed Gollob Board of Directors Award for breakthrough research conducted within the past year.
-
A Steady Hand in Saving Vision
Eye On the Cure Research NewsSubretinal injection is the most common form of delivery for gene therapies currently in clinical trials.
-
Fighting Blindness Gets Sheepish
Eye On the Cure Research NewsResearchers in Israel are developing a gene therapy for achromatopsia that may help both sheep and humans alike.
-
ARVO 2016: High-School Sophomore Finds Gene Mutation in Family with Choroideremia
Eye On the Cure Research NewsAditya A. Guru, 16, used whole exome sequencing (WES), an innovative genetic-screening technology, to find the mutation.
-
ARVO 2016: Emerging Drug Targets Toxic Build-Up in Stargardt Disease
Eye On the Cure Research NewsIn August 2015, the biotech company Alkeus launched a multi-center TEASE Phase II clinical trial for the drug ALK-001.
-
ARVO 2016: ProgSTAR, FFB-CRI's Stargardt Disease Patient Study, Highlighted
Eye On the Cure Research NewsWhen the study and the reports are completed, the ProgSTAR database will be made available to researchers and companies developing therapies.
-
ARVO 2016: Choroideremia Gene Therapy in Clinical Trial Continues to Perform Well
Eye On the Cure Research NewsFive of six patients in NightStaRx’s choroideremia gene-therapy trial continue to benefit from the treatment.
